Our Associate Scientific Director of Molecular Biology & Cell Engineering, Omar has a PhD from the School of Medicine at the University of St Andrews, with specific experience in cell and protein engineering.
Omar has worked across academia and industry since 2014 and joined RoukenBio in 2021. He has led the CLD operations at RoukenBio, delivering overexpression cell lines, reporter cell systems and our novel inducible IndEx-2 platform.
Resources
Insights
7 February 2025
|5 min read
What’s the future of cell engineering? We caught up with our experts to talk cell engineering, RoukenBio’s trademark IndEx-2 technology, and to introduce our new targeted integration system – LocIn.
Research Posters
15 September 2023
|3 min read
Explore our research poster as we analyse the data from our new cell line development platform, IndEx-2.
Whitepapers
19 October 2022
|6 min read
Target cells are a critical component of immune cell effector assays. Whether investigating TDCC or ADCC, we create engineered target cells uniquely suited for the evaluation of effector function and molecule specificity. But how do we achieve this and what are the principles we follow?
